Trial NCT00635024

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000589032
Secondary IDs: 06-005792 MC0687 P30CA015083

Last trial update was posted on 2017-02-10

MeSH Interventions

Antilymphocyte Serum Melphalan

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell Plasmacytoma

Other Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Stopping Reasons

Due to competing trials, this study is permanenlty closed to patient acrrual.

Limitations And Caveats

After 1 patient was recruited, this trial temporarily closed to allow the first dose of Anti-thymocyte Globulin to be split over two days. Before the modification was written, it was decided to permanently close this study due to competing trials.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID